Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor immunotherapy directed at PD-1.

Literature DB >> 22658126

Tumor immunotherapy directed at PD-1.

Antoni Ribas.

Abstract

Mesh：

Substances：

Year: 2012 PMID： 22658126 DOI： 10.1056/NEJMe1205943

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

243 in total

Review 1. Cholangiocarcinoma: molecular pathways and therapeutic opportunities.

Authors: Sumera Rizvi; Mitesh J Borad; Tushar Patel; Gregory J Gores
Journal: Semin Liver Dis Date: 2014-11-04 Impact factor: 6.115

2. Insights into the mechanism of organ-specific cancer metastasis.

Authors: Mark A Rubin
Journal: Cancer Discov Date: 2014-11 Impact factor: 39.397

3. Immune Checkpoint Blockade in Hepatocellular Carcinoma.

Authors: M Kudo
Journal: Liver Cancer Date: 2015-10-15 Impact factor: 11.740

Review 4. Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors: Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal: Adv Drug Deliv Rev Date: 2015-12-11 Impact factor: 15.470

Review 5. Adipocyte and lipid metabolism in cancer drug resistance.

Authors: Yihai Cao
Journal: J Clin Invest Date: 2019-07-02 Impact factor: 14.808

6. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.

Authors: Kimberly Loo; Katy K Tsai; Kelly Mahuron; Jacqueline Liu; Mariela L Pauli; Priscila M Sandoval; Adi Nosrati; James Lee; Lawrence Chen; Jimmy Hwang; Lauren S Levine; Matthew F Krummel; Alain P Algazi; Miguel Pampaloni; Michael D Alvarado; Michael D Rosenblum; Adil I Daud
Journal: JCI Insight Date: 2017-07-20

Tumor immunotherapy directed at PD-1.

Review 1. Cholangiocarcinoma: molecular pathways and therapeutic opportunities.

2. Insights into the mechanism of organ-specific cancer metastasis.

3. Immune Checkpoint Blockade in Hepatocellular Carcinoma.

Review 4. Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Review 5. Adipocyte and lipid metabolism in cancer drug resistance.

6. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.

7. Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.

Review 8. Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

Review 9. The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation.

10. New paradigms and future challenges in radiation oncology: an update of biological targets and technology.